BioLabs Global (“BioLabs”), a network of shared lab facilities for high-potential life-science startups in key biotech innovation clusters, today announces that Otsuka Pharmaceutical Co., Ltd., (Otsuka) has become a Networkwide Sponsor of BioLabs in the United States.
Otsuka has signed a three-year agreement with BioLabs to provide funding which will support BioLabs and their resident companies in the US. Otsuka is proud to grow our relationship with BioLabs’ community of startup companies. As part of the sponsorship, Otsuka can award up to two Golden Tickets per year. Recipients of a Golden Ticket are awarded a residence within BioLabs shared lab space for one year and are eligible to receive advisory support from Otsuka.
“We are excited to welcome Otsuka as our newest sponsor and strategic partner in helping advance innovative life sciences companies”, said Johannes Fruehauf, Founder and CEO, Biolabs. “with their active partnering strategy and global footprint, Otsuka will play a key role in supporting innovative new therapeutics companies within the BioLabs network.”
Otsuka will be launching their first Golden Ticket nomination process in June, 2023 with the intention of awarding two promising startup companies a one-year pre-paid residence at one of the BioLabs sites in the US in the Fall. Visit BioLabs’ website (https://www.biolabs.io/) for details on Otsuka’s key focus areas and application, including application criteria and full terms and conditions. And, come visit Otsuka’s booth at BIO (BF-B215).
About Otsuka (https://www.otsuka.co.jp/en/)
Otsuka Pharmaceutical Co., Ltd. is a global healthcare company with the corporate philosophy: Otsuka–people creating new products for better health worldwide. Otsuka researches, develops, manufactures, and markets innovative products, with a focus on pharmaceutical products to meet unmet medical needs and nutraceutical products for the maintenance of everyday health.
About BioLabs (www.biolabs.io twitter: @bioLabsHQ)
BioLabs is a membership-based network of shared lab facilities located in the nation’s key biotech innovation clusters. BioLabs offers co-working environments designed exclusively for high-potential, early-stage life science companies. We pair premium, fully equipped and supported lab and office space with unparalleled access to capital and industry partners. This fertile, supportive ecosystem allows nascent companies to shift their focus from startup operations to innovation so they can reach their scientific potential quickly and achieve business success. Companies can start with a single bench and scale up as they grow. BioLabs, headquartered in Cambridge, has additional locations and collaborations in 7 States, Europe and Japan.
For further information:
For BioLabs
Susan Chase Nanor Nerkizian Danielle Bogdanowicz
susan@biolabs.io nanor@biolabs.io DBogdanowicz@biolabs.io
